{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:38:43Z","timestamp":1793227123990,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Loyola College - Times of India Research Grant","award":["7LCTOIERI004"],"award-info":[{"award-number":["7LCTOIERI004"]}]},{"name":"University Grants Commission, New Delhi","award":["F1-17.1\/2014-15\/RGNF-2014-15-ST-JHA-59310\/(SA-111)\/25\/02\/2015"],"award-info":[{"award-number":["F1-17.1\/2014-15\/RGNF-2014-15-ST-JHA-59310\/(SA-111)\/25\/02\/2015"]}]},{"name":"King Saud University through ISPP","award":["ISPP#0020"],"award-info":[{"award-number":["ISPP#0020"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cbi.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T03:49:54Z","timestamp":1490413794000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models"],"prefix":"10.1016","volume":"269","author":[{"given":"Erenius","family":"Toppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Sylvester","family":"Darvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Esakkimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Balakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sivasankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pandikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-789X","authenticated-orcid":false,"given":"S.","family":"Ignacimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Al-Dhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2017.03.013_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"Diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American College of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cbi.2017.03.013_bib2","first-page":"1008","article-title":"Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone","volume":"38","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2017.03.013_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7861\/clinmedicine.7-2-119","article-title":"Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs","volume":"7","author":"Whalley","year":"2007","journal-title":"Clin. Med."},{"issue":"1","key":"10.1016\/j.cbi.2017.03.013_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.cbi.2017.03.013_bib5","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","article-title":"Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update","volume":"21","author":"Athyros","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2017.03.013_bib6","doi-asserted-by":"crossref","first-page":"e86724","DOI":"10.1371\/journal.pone.0086724","article-title":"Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cbi.2017.03.013_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/07853890802552437","article-title":"New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)","volume":"41","author":"Ali","year":"2009","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.cbi.2017.03.013_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2225-4110.110411","article-title":"Recent advances in the herbal treatment of non-alcoholic Fatty liver disease","volume":"3","author":"Xiao","year":"2013","journal-title":"J.\u00a0Tradit. Complement. Med."},{"key":"10.1016\/j.cbi.2017.03.013_bib9","series-title":"Wealth of India \u2013 Raw Materials","first-page":"3","author":"Anonymous","year":"2002"},{"key":"10.1016\/j.cbi.2017.03.013_bib10","series-title":"Wealth of India \u2013 raw materials","first-page":"165","author":"Anonymous","year":"2007"},{"key":"10.1016\/j.cbi.2017.03.013_bib11","first-page":"893","article-title":"Novel constituents of Gardenia species \u2013 a review","volume":"59","author":"Parmer","year":"2000","journal-title":"J.\u00a0Sci. Ind. Res."},{"key":"10.1016\/j.cbi.2017.03.013_bib12","first-page":"143","volume":"vol. 1","year":"2010"},{"key":"10.1016\/j.cbi.2017.03.013_bib13","doi-asserted-by":"crossref","first-page":"S633","DOI":"10.1111\/j.1750-3841.2006.00192.x","article-title":"Lipid-lowering effect of Eriocitrin, the main flavonoid in lemon fruit, in rats on a high-fat and high-cholesterol diet","volume":"71","author":"Miyake","year":"2006","journal-title":"J.\u00a0Food Sci."},{"issue":"7","key":"10.1016\/j.cbi.2017.03.013_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jn\/138.7.1274","article-title":"The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells","volume":"138","author":"Morin","year":"2008","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.cbi.2017.03.013_bib15","first-page":"1","article-title":"Chemistry and biological activities of flavonoids: an overview","author":"Kumar","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.cbi.2017.03.013_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.fct.2012.10.005","article-title":"Citrus peel polymethoxylated flavones extract modulates liver and heart function parameters in diet induced hypercholesterolemic rats","volume":"51","author":"Green","year":"2013","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2017.03.013_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0271-5317(96)00032-2","article-title":"Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids","volume":"16","author":"Manach","year":"1996","journal-title":"Nutr. Res."},{"issue":"2","key":"10.1016\/j.cbi.2017.03.013_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.15226\/2376-4589\/2\/2\/00113","article-title":"Enhancing the pharmaceutical properties of flavonoids via methylation and glycosylation","volume":"2","author":"Koirala","year":"2016","journal-title":"SOJ Biochem."},{"issue":"3","key":"10.1016\/j.cbi.2017.03.013_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmc.2012.11.035","article-title":"Enhanced bioactivity of silybin B methylation products","volume":"21","author":"Sy-Cordero","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2017.03.013_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cbi.2017.03.013_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1472-6882-14-253","article-title":"Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells","volume":"14","author":"Jang","year":"2014","journal-title":"Complement. Alt. Med."},{"issue":"6","key":"10.1016\/j.cbi.2017.03.013_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00316069","article-title":"Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O","volume":"97","author":"Ramirez-Zacarias","year":"1992","journal-title":"Histochemistry"},{"key":"10.1016\/j.cbi.2017.03.013_bib23","first-page":"652","article-title":"Effect of silybin on high-fat-induced fatty liver in rats","volume":"44","author":"Yao","year":"2011","journal-title":"Braz J. Med. Biol. Res."},{"key":"10.1016\/j.cbi.2017.03.013_bib24","first-page":"1","article-title":"Primary observation (Irwin) test in rodents for assessing acute toxicity of a test agent and its effect on behavior and physiological function","volume":"10","author":"Roux","year":"2004","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.cbi.2017.03.013_bib25","series-title":"Drug Discovery and Evaluation \u2013 Pharmacological Assays. Springer-Vergal","first-page":"606","article-title":"Anti-atherosclerotic activity: triton-induced hyperlipidaemia","author":"Vogel","year":"1997"},{"key":"10.1016\/j.cbi.2017.03.013_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.vascn.2006.05.009","article-title":"A\u00a0procedure for inducing sustained hyperlipidemia in rats by administration of a surfactant","volume":"55","author":"Levine","year":"2007","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.cbi.2017.03.013_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/002367707779399518","article-title":"Anthropometrical parameters and markers of obesity in rats","volume":"41","author":"Novelli","year":"2007","journal-title":"Lab. Anim."},{"key":"10.1016\/j.cbi.2017.03.013_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of Low-Density Lipoprotein Cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2017.03.013_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9422(00)97104-8","article-title":"Highly oxygenated bioactive flavones from taxmarin","volume":"36","author":"Parmar","year":"1994","journal-title":"Phytochemistry"},{"issue":"3","key":"10.1016\/j.cbi.2017.03.013_bib30","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cbi.2017.03.013_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.cbi.2017.03.013_bib32","first-page":"847539","article-title":"Chronic kidney disease and nonalcoholic fatty liver disease-is there a link?","volume":"6","author":"Orlic","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.cbi.2017.03.013_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2017.03.013_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: a practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"issue":"1","key":"10.1016\/j.cbi.2017.03.013_bib35","first-page":"95","article-title":"Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells","volume":"2","author":"Cui","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cbi.2017.03.013_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-511X-13-173","article-title":"Inhibiting CB1 receptors improves lipogenesis in an in\u00a0vitro non-alcoholic fatty liver disease model","volume":"13","author":"Shi","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.cbi.2017.03.013_bib37","first-page":"284","article-title":"Lipotoxicity in HepG2 cells triggered by free fatty acids","volume":"3","author":"Yao","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cbi.2017.03.013_bib38","first-page":"61","article-title":"Overview of animal models of obesity","volume":"5","author":"Lutz","year":"2012","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"11","key":"10.1016\/j.cbi.2017.03.013_bib39","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.3390\/ijms141121240","article-title":"Lessons from mouse models of high-fat diet-induced NAFLD","volume":"14","author":"Nakamura","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2017.03.013_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","article-title":"Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus","volume":"29","author":"Leite","year":"2009","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.cbi.2017.03.013_bib41","first-page":"712","article-title":"Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?","volume":"25","author":"Rodriguez","year":"2010","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.cbi.2017.03.013_bib42","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"Br. Med. J."},{"issue":"10","key":"10.1016\/j.cbi.2017.03.013_bib43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/MCB.01321-14","article-title":"Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation","volume":"35","author":"Kim","year":"2015","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.cbi.2017.03.013_bib44","doi-asserted-by":"crossref","first-page":"e105262","DOI":"10.1371\/journal.pone.0105262","article-title":"Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes","volume":"9","author":"Henninger","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2017.03.013_bib45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats","volume":"51","author":"Cipriani","year":"2010","journal-title":"J.\u00a0Lipid Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717300595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717300595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:43:20Z","timestamp":1757857400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717300595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":45,"alternative-id":["S0009279717300595"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.03.013","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}